DiaMedica Therapeutics Inc. (DMAC)

DiaMedica Therapeutics Statistics

Total Valuation

DMAC has a market cap or net worth of $433.28 million. The enterprise value is $394.38 million.

Market Cap	433.28M
Enterprise Value	394.38M

Important Dates

The last earnings date was Wednesday, November 12, 2025, after market close.

Earnings Date	Nov 12, 2025
Ex-Dividend Date	n/a

Share Statistics

DMAC has 52.08 million shares outstanding. The number of shares has increased by 13.70% in one year.

Current Share Class	52.08M
Shares Outstanding	52.08M
Shares Change (YoY)	+13.70%
Shares Change (QoQ)	+15.53%
Owned by Insiders (%)	47.77%
Owned by Institutions (%)	24.19%
Float	23.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	8.71
P/TBV Ratio	8.71
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.67, with a Debt / Equity ratio of 0.01.

Current Ratio	10.67
Quick Ratio	10.55
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -64.12% and return on invested capital (ROIC) is -41.91%.

Return on Equity (ROE)	-64.12%
Return on Assets (ROA)	-38.33%
Return on Invested Capital (ROIC)	-41.91%
Return on Capital Employed (ROCE)	-64.90%
Revenue Per Employee	n/a
Profits Per Employee	-$1.14M
Employee Count	28
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, DMAC has paid $27,000 in taxes.

Income Tax	27,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +50.31% in the last 52 weeks. The beta is 1.32, so DMAC's price volatility has been higher than the market average.

Beta (5Y)	1.32
52-Week Price Change	+50.31%
50-Day Moving Average	6.94
200-Day Moving Average	5.31
Relative Strength Index (RSI)	64.54
Average Volume (20 Days)	500,582

Short Selling Information

The latest short interest is 5.00 million, so 9.61% of the outstanding shares have been sold short.

Short Interest	5.00M
Short Previous Month	4.12M
Short % of Shares Out	9.61%
Short % of Float	20.91%
Short Ratio (days to cover)	16.22

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-33.60M
Pretax Income	-31.90M
Net Income	-31.93M
EBITDA	-33.56M
EBIT	-33.60M
Earnings Per Share (EPS)	-$0.72

Balance Sheet

The company has $55.32 million in cash and $266,000 in debt, giving a net cash position of $55.05 million or $1.06 per share.

Cash & Cash Equivalents	55.32M
Total Debt	266,000
Net Cash	55.05M
Net Cash Per Share	$1.06
Equity (Book Value)	51.62M
Book Value Per Share	0.99
Working Capital	50.96M

Cash Flow

In the last 12 months, operating cash flow was -$27.73 million and capital expenditures -$41,000, giving a free cash flow of -$27.77 million.

Operating Cash Flow	-27.73M
Capital Expenditures	-41,000
Free Cash Flow	-27.77M
FCF Per Share	-$0.53

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DMAC does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.70%
Shareholder Yield	-13.70%
Earnings Yield	-7.10%
FCF Yield	-6.18%

Analyst Forecast

The average price target for DMAC is $15.50, which is 86.30% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.50
Price Target Difference	86.30%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-10.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 15, 2018. It was a reverse split with a ratio of 1:20.

Last Split Date	Nov 15, 2018
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	1